In the Conclusions, there is an error in the sentence that says:
We believe that the chances are small that IL21 as monotherapy or combination therapy may be efficacious in late-stage cancers such as stage IV metastatic melanoma or renal cell carcinoma.
The correct version is:
We believe that IL21 as monotherapy or combination therapy may be efficacious in late-stage cancers such as stage IV metastatic melanoma or renal cell carcinoma.
Additional information
The online version of the original article can be found at 10.1038/nrd2482
Rights and permissions
About this article
Cite this article
Skak, K., Kragh, M., Hausman, D. et al. Erratum: Interleukin 21: combination strategies for cancer therapy. Nat Rev Drug Discov 7, 272 (2008). https://doi.org/10.1038/nrd2551
Issue Date:
DOI: https://doi.org/10.1038/nrd2551
